Francisco Javier
López Jiménez
Profesor/a Asociado/a en CC. de la Salud
Institute Catalá Oncología
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institute Catalá Oncología (8)
2023
-
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
Frontiers in Immunology, Vol. 14
-
Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study
British Journal of Haematology, Vol. 203, Núm. 2, pp. 182-193
2014
-
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: Do we still need alkylators?
Blood, Vol. 124, Núm. 12, pp. 1887-1893
-
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia
Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 10, pp. 5758-5765
-
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
Haematologica, Vol. 99, Núm. 10, pp. 1632-1637
2012
-
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial
Blood, Vol. 120, Núm. 13, pp. 2581-2588
2002
-
Dynamic filters for the spectral analysis of random signals
Measurement Techniques, Vol. 45, Núm. 5, pp. 544-551
-
The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant period
Bone Marrow Transplantation, Vol. 29, Núm. 9, pp. 737-743